Bradford J. Gessner, M.D., M.P.H.

Vice President Global Medical Lead for Respiratory Vaccines
Pfizer Biopharma Group

Disclosure(s): Pfizer Inc.: Employee, Stocks/Bonds

Poster(s):

• 371 - Adding sputum and saliva to nasopharyngeal swab samples for PCR detection of Respiratory Syncytial Virus in adults hospitalized with acute respiratory illness may double case detection
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 586 - Systematic Literature Review of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) Effectiveness Against Invasive Pneumococcal Disease in Children Globally
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1462 - Validating a claims-based algorithm for Lyme Disease in Massachusetts
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 2207 - Rates of Lower Respiratory Tract Infections Among US Adults Aged ≥18 Years With and Without Chronic Medical Conditions
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET